Target Name: PRRG1
NCBI ID: G5638
Other Name(s): PRGP1 | PRRG1 variant 2 | Proline rich and Gla domain 1, transcript variant 2 | Proline-rich Gla protein 1 | Transmembrane gamma-carboxyglutamic acid protein 1 | OTTHUMP00000215931 | TMG1_HUMAN | Proline rich Gla (G-carboxyglutamic acid) 1 | Proline-rich gamma-carboxyglutamic acid protein 1 | Proline-rich Gla (G-carboxyglutamic acid) polypeptide 1 | TMG1 | PRRG1 variant 1 | OTTHUMP00000215928 | proline rich and Gla domain 1 | Transmembrane gamma-carboxyglutamic acid protein 1 (isoform 1) | proline rich Gla (G-carboxyglutamic acid) 1 | proline-rich Gla (G-carboxyglutamic acid) polypeptide 1 | Proline rich Gla (G-carboxyglutamic acid) 1, transcript variant 1

PRRG1: A Protein with Potential as A Drug Target and Biomarker

PRRG1 (PRGP1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and intestines. It is a member of the PRG family of proteins, which are involved in the regulation of cell signaling pathways. PRRG1 has been shown to play a role in several physiological processes, including cell signaling, neurodegeneration, and inflammation.

One of the most promising aspects of PRRG1 is its potential as a drug target. PRRG1 has been shown to interact with several different signaling pathways, including the TGF-β pathway and the Wnt pathway. These interactions make PRRG1 a potential target for drugs that are designed to modulate these pathways.

In addition to its potential as a drug target, PRRG1 is also a potential biomarker. The Rabies virus is a highly lethal virus that infects animals and causes rabies. PRRG1 has been shown to be expressed in the brains of infected animals, and it has been suggested as a potential biomarker for the disease.

PRRG1 is also a potential target for drug development due to its unique structure and biology. PRRG1 is a transmembrane protein, which means that it spans the cell membrane and is involved in the regulation of intracellular signaling pathways. This unique structure makes PRRG1 a potential target for drugs that can modulate the activity of transmembrane proteins.

In conclusion, PRRG1 is a protein that has the potential to be a drug target and a biomarker. Its unique structure and biology make it an attractive target for drug development, and its interactions with multiple signaling pathways make it a promising target for the treatment of a wide range of diseases. Further research is needed to fully understand the role of PRRG1 in biology and to develop effective drugs that can modulate its activity.

Protein Name: Proline Rich And Gla Domain 1

More Common Targets

PRRG2 | PRRG3 | PRRG4 | PRRT1 | PRRT2 | PRRT3 | PRRT3-AS1 | PRRT4 | PRRX1 | PRRX2 | PRSS1 | PRSS12 | PRSS16 | PRSS2 | PRSS21 | PRSS22 | PRSS23 | PRSS27 | PRSS3 | PRSS30P | PRSS33 | PRSS35 | PRSS36 | PRSS37 | PRSS38 | PRSS3P1 | PRSS3P2 | PRSS3P3 | PRSS40A | PRSS41 | PRSS42P | PRSS45P | PRSS46P | PRSS48 | PRSS50 | PRSS53 | PRSS54 | PRSS55 | PRSS56 | PRSS57 | PRSS58 | PRSS59P | PRSS8 | PRTFDC1 | PRTG | PRTN3 | PRUNE1 | PRUNE2 | PRX | PRXL2A | PRXL2B | PRXL2C | PRY | PRY2 | PRYP3 | PRYP4 | PSAP | PSAPL1 | PSAT1 | PSAT1P1 | PSAT1P3 | PSCA | PSD | PSD2 | PSD3 | PSD4 | PSEN1 | PSEN2 | PSENEN | PSG1 | PSG10P | PSG11 | PSG2 | PSG3 | PSG4 | PSG5 | PSG6 | PSG7 | PSG8 | PSG9 | PSIP1 | PSKH1 | PSKH2 | PSMA1 | PSMA2 | PSMA3 | PSMA3-AS1 | PSMA3P1 | PSMA4 | PSMA5 | PSMA6 | PSMA7 | PSMA8 | PSMB1 | PSMB10 | PSMB11 | PSMB2 | PSMB3 | PSMB3P2 | PSMB4